DowWeakened a little today The market continued to gain momentum from the forecast that Food and Drug AdministrationUnited States (FDA) will introduce a vaccine against COVID-19. Of Pfizer Inc.
As of 21.46 GMT, the Dow Jones Industrial Average was 30,046.99, minus 22.80 points, or 0.08%.
The FDA said today. Data from Pfizer Inc.’s COVID-19 vaccine trials do not raise safety concerns.
A document published today on the FDA’s website states that the company’s vaccine trial data is consistent with the FDA’s proposal for emergency vaccine (EUA) approval.
“The FDA has determined that it has provided sufficient information to ensure the quality of the vaccine. And complies with EUA product approvals, “the FDA stated.
The FDA also revealed that The information says Pfizer vaccine against COVID-19 After the first injection. 3 weeks prior to the second injection
The FDA is scheduled to hold an advisory committee meeting on Thursday to determine the qualifications of Pfizer’s COVID-19 vaccine.If the board agrees to approve the vaccine, the FDA will then announce a formal approval thereafter. Just a few days
At the same time, investors still keep an eye on the progress in issuing US economic stimulus measures.
U.S. House of Representatives Seni Hoyer said the House of Representatives would vote on a temporary budget bill to avoid a one-week shutdown of government agencies. Tomorrow And to give MPs more time to negotiate a deal to issue a $ 9.08 billion stimulus package to mitigate the effects of the COVID-19 epidemic.
U.S. House Speaker Nancy Pelosi and Senate Majority Leader Mitch McConnell It expressed hope that Congress will be able to reach an agreement on the issuance of economic stimulus and provisional budget legislation by Dec. 11, the last day before US government agencies face a shutdown.
– .
